Download PDF

Other users also viewed these articles

Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco; Esteban Rubio-Romero; Raimon Sanmartí; César Díaz-Torné; Pablo Talavera; Jochen Dunkel; Esperanza Naredo;
Reumatol Clin. 2020;16P1:345-52
Achlorophyllic algae and chronic bursitis: An exceptional association Pablo González del Pozo; Paula Álvarez Peñalba; Stefanie Burger; Norma Alejandra Callejas Pineda; Rubén Queiro Silva; Sara Alonso Castro;
10.1016/j.reumae.2025.501920
Does human microbiota interact with immunosuppressive treatment of systemic autoimmune rheumatological diseases? A systematic review Noemí Franco-Domingo; Patricia Saiz-López; Loreto Carmona-Ortells;
10.1016/j.reumae.2025.501938